- $5.43bn
- $13.39bn
- $1.83bn
- 78
- 94
- 52
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 93 | 182 | 258 | 248 | 223 |
Net Total Receivables | 739 | 245 | 720 | 439 | 536 |
Prepaid Expenses | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 8,216 | 7,237 | 17,228 | 16,124 | 15,469 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4,350 | 4,141 | 9,498 | 9,112 | 8,620 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3,866 | 3,096 | 7,730 | 7,012 | 6,849 |
Total Liabilities & Shareholders' Equity | 8,216 | 7,237 | 17,228 | 16,124 | 15,469 |
Total Common Shares Outstanding |